Ticker >

Alpa Lab share price

Alpa Laboratories Ltd.

NSE: ALPA BSE: 532878 SECTOR: Pharmaceuticals & Drugs  27k   96   7

83.20
-1.40 (-1.65%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 86.26

Today's Low

₹ 83.1

52 Week High

₹ 115

52 Week Low

₹ 51

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

175.06 Cr.

Enterprise Value

168.86 Cr.

No. of Shares

2.1 Cr.

P/E

9.77

P/B

1.11

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  75.02

CASH

8.79 Cr.

DEBT

2.59 Cr.

Promoter Holding

57.29 %

EPS (TTM)

₹  8.52

Sales Growth

-17.2%

ROE

9.14 %

ROCE

11.35%

Profit Growth

-10.63 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-17.2%
3 Year2.64%
5 Year8.34%

Profit Growth

1 Year-10.63%
3 Year45.74%
5 Year21.51%

ROE%

1 Year9.14%
3 Year8.95%
5 Year6.69%

ROCE %

1 Year11.35%
3 Year12.14%
5 Year9.21%

Debt/Equity

0.0179

Price to Cash Flow

19.85

Interest Cover Ratio

72.3151298119964

CFO/PAT (5 Yr. Avg.)

0.64643937049698

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 57.29 0
Sep 2023 57.29 0
Jun 2023 57.29 0
Mar 2023 57.29 0
Dec 2022 57.29 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 45.7414698264778% for the Past 3 years.
  • The company has significantly decreased its debt by 3.2534 Cr.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 72.3151298119964.
  • Company has a healthy liquidity position with current ratio of 4.95439822165767.
  • The company has a high promoter holding of 57.29%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 4.80311879203312.

 Limitations

  • The company has shown a poor revenue growth of 2.63850636074541% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 27.31 29.16 25.43 32.39 27.31
Total Expenditure 24.69 19.9 26.58 29.08 24.85
Operating Profit 2.62 9.26 -1.15 3.32 2.46
Other Income 2.69 -0.76 4.44 2.95 3.53
Interest 0.07 0.04 0.02 0.04 0.03
Depreciation 0.1 0.53 0.28 0.49 0.66
Exceptional Items 0 0 0.03 0 0.02
Profit Before Tax 5.14 7.93 3.03 5.74 5.32
Tax 0 3.31 0 0 0.79
Profit After Tax 5.14 4.62 3.03 5.74 4.53
Adjusted EPS (Rs) 2.44 2.2 1.44 2.73 2.15

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 77.99 85.97 97.55 112.27 92.96
Total Expenditure 76.77 82.52 89.85 101.58 84.88
Operating Profit 1.22 3.45 7.71 10.69 8.08
Other Income 5.07 2.97 4.41 10.79 9.41
Interest 0.57 0.2 0.1 0.24 0.22
Depreciation 1.1 1.14 1.23 1.66 1.33
Exceptional Items 0 0 0 0 0
Profit Before Tax 4.62 5.08 10.79 19.58 15.93
Tax 1.67 1 3.53 5.45 3.31
Net Profit 2.95 4.08 7.26 14.13 12.62
Adjusted EPS (Rs.) 1.4 1.94 3.45 6.71 6

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 21.04 21.04 21.04 21.04 21.04
Total Reserves 85.09 89.19 96.48 110.6 123.49
Borrowings 0.41 0.19 0.01 2.12 0.78
Other N/C liabilities -0.17 -0.93 0.22 2.57 2.28
Current liabilities 22.28 20.78 32.49 28.8 29.92
Total Liabilities 128.65 130.28 150.23 165.14 177.5
Assets
Net Block 5.76 6.42 7.21 9.32 7.04
Capital WIP 0.12 0.81 1.57 0 0
Intangible WIP 0 0 0 0 0
Investments 29.47 28.31 21.24 17.03 17.57
Loans & Advances 0.13 0.24 0.23 0.22 1.45
Other N/C Assets 0.3 0.2 0.11 1.76 3.23
Current Assets 92.87 94.29 119.87 136.81 148.21
Total Assets 128.65 130.28 150.23 165.14 177.5
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 4.62 5.08 10.79 19.58 15.72
Adjustment -1.07 3.7 0.71 -7.95 -2.44
Changes in Assets & Liabilities -2.14 9.99 -10.11 -5.85 -1.06
Tax Paid -2.09 -1.1 -2.87 -3.57 -3.41
Operating Cash Flow -0.68 17.66 -1.47 2.2 8.82
Investing Cash Flow -14.95 -11.27 5.82 -15.61 2.14
Financing Cash Flow -4.78 -1.35 -0.03 5.41 -3.48
Net Cash Flow -20.4 5.03 4.32 -7.99 7.48

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 57.29 57.29 57.29 57.29 57.29
asha chawla 2.93 2.93 2.93 2.93 2.93
bakulesh chandulal shah h... 0.10 0.10 0.10 0.10 0.10
bakulesh shah 4.88 4.88 4.88 4.88 4.88
mahendra singh chawla 13.82 13.82 13.82 13.82 13.82
paresh chawla 17.52 17.52 17.52 17.52 17.52
pravin shah 5.75 5.75 5.75 5.75 5.75
rima shah 3.68 3.68 3.68 3.68 3.68
rupal shah 2.66 2.66 2.66 2.66 2.66
shitul shah 4.40 4.40 4.40 4.40 4.40
soni chawla 1.55 1.55 1.55 1.55 1.55
PARTICULARS Mar 2018% Jun 2018% Sep 2018% Dec 2018% Mar 2019%
investors 45.39 45.39 45.39 45.39 43.34
jasmin kishor ajmera 1.06 1.06 1.06 1.06 1.06
shanti rani chawla 1.73 1.73 1.73 1.73 -

Annual Reports

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Alpa Lab Stock Price Analysis and Quick Research Report. Is Alpa Lab an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Alpa Lab and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Alpa Lab cash from the operating activity was Rs 8.8196 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Alpa Lab has a Debt to Equity ratio of 0.0179 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Alpa Lab , the EPS growth was -10.6291706387035 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Alpa Lab has OPM of 8.68805618190269 % which is a bad sign for profitability.
     
  • ROE: Alpa Lab have a poor ROE of 9.14250166475176 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Alpa Lab is Rs 83.25. One can use valuation calculators of ticker to know if Alpa Lab share price is undervalued or overvalued.
Last Updated on:
Brief about Alpa Lab
X